Loading organizations...
§ Venture Capital
Progeny Plus Capital Partners operates as a venture capital firm with a strategic focus on early-stage investments within the technology and healthcare sectors. The firm specializes in deploying capital to foster innovation and accelerate market expansion for nascent companies. It employs a disciplined approach to identifying promising ventures, targeting those with scalable solutions and robust leadership poised for significant impact.
The firm's establishment was driven by an acute recognition of burgeoning opportunities across the technology and healthcare sectors. It was founded to address the capital needs of emerging companies, leveraging deep industry expertise to identify and nurture ventures poised for significant growth. This foundation reflects a commitment to empowering innovative solutions.
Progeny Plus Capital Partners serves a diverse set of founders and entrepreneurial teams building transformative products in technology and healthcare. Its vision centers on enabling breakthrough advancements, supporting companies that aim to redefine their respective markets. The firm actively seeks to build enduring partnerships that contribute to long-term economic and societal value.
Progeny Plus Capital Partners has 1 tracked investment across 1 company. The latest tracked deal is $4.2M Series A in Sway Medical in September 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 24, 2020 | Sway Medical | $4.2M Series A | Atento Capital, Oklahoma Life Science Fund | Eric Warren, Will Smith, ADG, Cortado Ventures, Innovation IN Motion |